Brief: Evofem Biosciences Announces $10 Million Registered Direct Offering Of Series B Preferred Stock
12/10/2021 11:34
Oct 12 (Reuters) - Evofem Biosciences Inc EVFM.O :
* EVOFEM BIOSCIENCES ANNOUNCES $10 MILLION REGISTERED DIRECT
OFFERING OF SERIES B PREFERRED STOCK
* EVOFEM BIOSCIENCES INC - PROVIDES RUNWAY INTO Q1 2022
Source text for Eikon: ID:nPn99Kx0Ba
Further company coverage: EVFM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evofem Biosciences
See all newsBrief: Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
Brief: HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition Of Evofem Notes
Evofem Biosciences Q1 sales edge up on higher pricing
Evofem Biosciences Q3 net sales rise
Brief: Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting